Quality Comes First EN Sorry, your browser doesn't support embedded videos. Innovation & Research HOME INNOVATION & RESEARCH Menarini, focused on making a difference For over 30 years, Menarini has been driving research and development to deliver innovative and effective medicines and healthcare solutions for patients affected by serious health conditions. At Menarini we understand that patients’ hope for a better life is inextricably linked to the persistence and progress of our researchers – that is what drives us forward. With 10 research centers across Europe, the US and Southeast Asia, MENARINI R&D develops projects from the preclinical phase to drug registration. Our Approach to R&D Our R&D division is focused on developing innovation in life sciences to improve the health of patients. In collaboration with our Business Development & Licensing and Marketing teams, we identify the most promising opportunities and apply our expertise in drug development to transform them into high-quality medicines that will improve patients’ lives. Continued investments in technology and in enhancing the skills and knowledge of our researchers means that we can deliver scientific breakthroughs and meaningfully contribute to finding cures for difficult-to-treat diseases. Our research areas We are strengthening our pipeline with a focus on science related to oncology and infectious diseases, two areas where we are well positioned to develop innovative therapies and to bring to patients in need. Oncology Working tirelessly to give hope to patients with difficult to treat cancers READ MORE Infectious Diseases Committed to contributing to the fight against antimicrobial resistance READ MORE Our pipeline and products Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions. READ MORE Clinical trials The Menarini Group is committed to enhancing public health trough responsible sharing of clinical trial data. READ MORE PARTNERING Drug development is a challenging process, and success relies on the integration of innovative scientific discoveries with the necessary capabilities and resources to transform them into effective healthcare solutions. READ MORE 8 1 MAIN LOCATIONS MANUFACTURING SITES RESEARCH CENTERS LOCAL OFFICES DISTRIBUTORS "Use the key combination "ctrl" + "mouse wheel" or the "+" and "-" buttons at the bottom right to browse the map" NEWS READ ALL NEWS 2021 - 11 - 4 Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia Florence (Italy) November 4th, 2021 – The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for... READ MORE 2021 - 10 - 20 Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer Florence, Italy and Boston, Mass., October 20, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the... READ MORE 2021 - 10 - 19 Serie A: the Volpi Rosse Menarini are ready to meet the challenge On 23 October, the first wheelchair basketball team in Tuscany will take part in the Serie A of the National Championship of the FIPIC (Italian Wheelchair Basketball Federation). The... READ MORE Contact Us Terms and conditions Data Privacy Sitemap Pharmacovigilance Cookie Setting Follow Us A.Menarini Industrie Farmaceutiche Riunite S.r.l. VAT number and registration number in the Company House: 00395270481 Office of the Companies House: Florence Share Capital: € 150.000.0000 I.V. © 2021 The Menarini Group - All rights reserved SHARE ON Facebook Twitter SCROLL TO TOP ABOUT US EXECUTIVE TEAM OUR HISTORY OUR COMMITMENT TO SCIENCE OUR ROOTS SUSTAINABILITY Our Values Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history. READ MORE KEY AREAS GASTROINTESTINAL DISORDERS PAIN MEN'S HEALTH LIFESTYLE OTCS VITAMINS, MINERALS & SUPPLEMENTS Oncology OUR MANIFESTO AND VISION BPDCN HEMATOLOGIC MALIGNANCIES (CD123) ACUTE MYELOID LEUKEMIA CHRONIC MYELOMONOCYTIC LEUKEMIA BREAST CANCER COLORECTAL CANCERS Are you looking for a specific product? SEARCH A PRODUCT INNOVATION & RESEARCH READ MORE PARTNERING COLLABORATION WITH STRATEGIC PARTNERS DERMA - AESTHETIC MEDICINE Share Your Innovative Idea Our corporate dedicated Business Development team is committed to assess and explore innovative new opportunities. CONTACT US RESPONSIBILITY MENARINI AGAINST COVID-19 Our Values Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history. READ MORE NEWS & MORE INTERNATIONAL FAIR PLAY MENARINI AWARD Menarini Blog Discover our stories from all over the world READ MORE FOLLOW US CAREERS Available positions on Linkedin Menarini employees make all the difference, every day. FOLLOW US ON LINKEDIN COUNTRIES Choose an area Main Locations Manufacturing Sites Research Centers Local Offices BROWSE ON MAP Our headquarter A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL Via Sette Santi, 1 50131 - Firenze (Firenze) Phone +39 055 56801 Fax +39 055 582771 CONTACT US Careers In Menarini I want to report a problem Report a problem with a product or an adverse drug reaction Report a concern related to a code of conduct violation Issues with Menarini's Website or Apps Our website uses cookies, including third party cookies. In addition to Strictly necessary cookies that are essential to browse the website, the site features Functional cookies that ensure you make the most of your browsing experience, Performance cookies, that perform aggregate statistics on the website usage, as well as Targeting cookies that automatically tailor on-line ads on the preferences you expressed while browsing this or other websites. Should you wish to receive more information click on the Cookie Policy. To inhibit Functional cookies, Performance cookies, Targeting cookies and/or cookies of specific third parties click on MORE OPTIONS. By clicking I ACCEPT you will be accepting all the mentioned types of cookies. I ACCEPT MORE OPTIONS